Dianthus Therapeutics, Inc. (DNTH)
NASDAQ·Healthcare·Biotechnology
$79.60
+0.34%
Mkt Cap $4.29B
Analyst Ratings
Buy
6
Hold
0
Sell
0
Price Target (23 analysts)
$126.83
Range $98.00 – $158.00
Implied Upside
+59.3%
Consensus $126.83 vs current $79.60
NASDAQ·Healthcare·Biotechnology
$79.60
+0.34%
Mkt Cap $4.29B
Buy
6
Hold
0
Sell
0
Price Target (23 analysts)
$126.83
Range $98.00 – $158.00
+59.3%
Consensus $126.83 vs current $79.60